Our work reveals a critical role for CHIP-dependent ubiquitination and microautophagy in lysosomal damage control and suggests that modulation of this lysosome protection mechanism may hold therapeutic promise for ameliorating lysosomal dysfunction in CLN4 and other aggregate-associated neurodegenerative diseases. The gene discussed is DNAJC5; the disease is neurodegenerative disease.